FDA Adverse Event Injury Summary report: N

ENROUTE NEUROPROTECTION SYSTEM

MDR report key: 14522929 · Received May 27, 2022

Report

Report Number
3014526664-2022-00085
Event Type
Injury
Date Received
May 27, 2022
Date of Event
May 20, 2022
Report Date
May 27, 2022
Manufacturer
SILK ROAD MEDICAL INC.
Product Code
NTE
UDI-DI
00811311020829
PMA / PMN Number
K153485
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CT, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE RESPONSIBLE FOR THE DISSECTION WAS NOT IDENTIFIED BY THE USER. AT THIS TIME, IT IS UNKNOWN IF THE REPORTED FAILURE IS RELATED TO THE MICROPUNCTURE KIT (MPK) OR THE ENROUTE NEUROPROTECTION SYSTEM (NPS); HENCE, THE EVENT WILL BE REPORTED OUT OF ABUNDANCE OF CAUTION. THE NPS ASSOCIATED WITH THIS COMPLAINT WAS NOT RETURNED TO THE MANUFACTURER FOR ANALYSIS. A REVIEW OF THE MANUFACTURING RECORDS FOR THIS DEVICE WAS COMPLETED AND NO ISSUES WERE IDENTIFIED THAT COULD HAVE LED TO THE ADVERSE EVENT REPORTED. A FOLLOW-UP MDR WILL BE SUBMITTED IF ADDITIONAL INFORMATION IS OBTAINED. COMPLAINTS WILL CONTINUE TO BE REVIEWED AND MONITORED FOR TRENDS.

Description of Event or Problem · 0

IT WAS REPORTED THAT DURING A TRANSCAROTID ARTERY REVASCULARIZATION (TCAR) PROCEDURE, INTRAVASCULAR ULTRASOUND (IVUS) REVEALED A DISSECTION IN THE COMMON CAROTID ARTERY (CCA). AN UNPLANNED STENT WAS USED TO COVER THE DISSECTION, AND THE PROCEDURE WAS COMPLETED. NO FURTHER COMPLICATIONS WERE REPORTED. THE DEVICE RESPONSIBLE FOR THE DISSECTION WAS NOT IDENTIFIED BY THE USER. AT THIS TIME, IT IS UNKNOWN IF THE REPORTED FAILURE IS RELATED TO THE MICROPUNCTURE KIT (MPK) OR THE ENROUTE NEUROPROTECTION SYSTEM (NPS); HENCE, THE EVENT WILL BE REPORTED OUT OF ABUNDANCE OF CAUTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1503151 ENROUTE NEUROPROTECTION SYSTEM TEMPORARY CAROTID CATHETER FOR EMBOLIC CAPTURE NTE SILK ROAD MEDICAL INC. SR-200-NPS 302267 00811311020829

Patients

Seq Age Sex Outcome Treatment
1 88 YR Female Required Intervention